Avidity’s del-zota treatment improved muscle function, increased dystrophin levels, and reduced damage markers in Duchenne muscular dystrophy after one year.
Avidity Drug Shows Yearlong Gains In Duchenne Muscular Dystrophy Trial
Where Today's News Shapes Tomorrow
